NO 8 Pill - yellow oval, 12mm
Pill with imprint NO 8 is Yellow, Oval and has been identified as Ondansetron Hydrochloride 8 mg. It is supplied by Sun Pharmaceutical Industries Inc.
Ondansetron is used in the treatment of Nausea/Vomiting; Nausea/Vomiting, Postoperative; Nausea/Vomiting, Chemotherapy Induced; Nausea/Vomiting, Radiation Induced and belongs to the drug class 5HT3 receptor antagonists. There is no proven risk in humans during pregnancy. Ondansetron 8 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for NO 8
Ondansetron Hydrochloride
- Imprint
- NO 8
- Strength
- 8 mg
- Color
- Yellow
- Size
- 12.00 mm
- Shape
- Oval
- Availability
- Prescription only
- Drug Class
- 5HT3 receptor antagonists
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Sun Pharmaceutical Industries Inc.
- Inactive Ingredients
-
microcrystalline cellulose,
croscarmellose sodium,
ferric oxide yellow,
hypromelloses,
lactose monohydrate,
magnesium stearate,
corn starch,
titanium dioxide,
triacetin
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 45963-0539 (Discontinued) | Actavis Pharma, Inc. |
| 63304-0459 | Ranbaxy Pharmaceuticals Inc. |
| 67877-0170 | Ascend Laboratories LLC |
Related images for "NO 8"
More about ondansetron
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (502)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: 5HT3 receptor antagonists
- Breastfeeding
Patient resources
- Ondansetron drug information
- Ondansetron injection
- Ondansetron (Oral, Oromucosal) (Advanced Reading)
Other brands
Professional resources
- Ondansetron monograph
- Ondansetron (FDA)
- Ondansetron Injection (FDA)
- Ondansetron ODT (FDA)
- Ondansetron Oral Solution (FDA)
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.